BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30178893)

  • 61. A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan.
    Yagi A; Ueda Y; Nakagawa S; Masuda T; Miyatake T; Ikeda S; Abe H; Hirai K; Sekine M; Miyagi E; Enomoto T; Nakayama T; Kimura T
    Cancer Sci; 2021 Sep; 112(9):3691-3698. PubMed ID: 34252250
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
    Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
    Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A comparison of diagnostic indicators of cervical cancer screening among women accessing through volunteer organisations and those via the organised programme in Turin (Piedmont Region, Northern Italy).
    Ferrante G; Castagno R; Rizzolo R; Armaroli P; Caprioglio A; Larato C; Giordano L
    Epidemiol Prev; 2020; 44(5-6 Suppl 1):115-123. PubMed ID: 33415954
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in Adolescent Girls in Taiwan.
    Tang CH; Cheng WF; Jiang JH; You SL; Huang LW; Hsieh JY; Mukherjee P; Van Kriekinge G; Lee C
    Asian Pac J Cancer Prev; 2019 May; 20(5):1377-1387. PubMed ID: 31127896
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States.
    Hariri S; Johnson ML; Bennett NM; Bauer HM; Park IU; Schafer S; Niccolai LM; Unger ER; Markowitz LE;
    Cancer; 2015 Aug; 121(16):2775-81. PubMed ID: 26098295
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The challenges of organising cervical screening programmes in the 15 old member states of the European Union.
    Arbyn M; Rebolj M; De Kok IM; Fender M; Becker N; O'Reilly M; Andrae B
    Eur J Cancer; 2009 Oct; 45(15):2671-8. PubMed ID: 19695867
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Questionnaire survey on the prevention and development of cervical cancer in patients with systemic lupus erythematosus in Japan.
    Murakawa Y; Dobashi H; Kondo M; Nishiyama S; Okazaki R; Hasegawa Y; Moriyama M; Sugiura T; Onishi I; Honda M; Nagamura N; Yoshioka Y; Minamoto T
    Mod Rheumatol; 2024 Feb; 34(2):352-358. PubMed ID: 36929382
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human papillomavirus in 2019: An update on cervical cancer prevention and screening guidelines.
    Zhang S; Batur P
    Cleve Clin J Med; 2019 Mar; 86(3):173-178. PubMed ID: 30849035
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Burden of disease associated with cervical cancer in malaysia and potential costs and consequences of HPV vaccination.
    Aljunid S; Zafar A; Saperi S; Amrizal M
    Asian Pac J Cancer Prev; 2010; 11(6):1551-9. PubMed ID: 21338196
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort.
    Kamineni A; Tiro JA; Beaber EF; Silverberg MJ; Wheeler CM; Chao CR; Chubak J; Skinner CS; Corley DA; Kim JJ; Balasubramanian BA; Paul Doria-Rose V;
    Int J Cancer; 2019 Mar; 144(6):1460-1473. PubMed ID: 30353911
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention.
    Obstet Gynecol; 2016 Oct; 128(4):e111-e130. PubMed ID: 27661651
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Screening for cervical cancer and human papillomavirus vaccination in Israel: recommendations.
    Bornstein J; Fisher WA; Ginsberg GM; Shavit O; Schejter E; Diaz M; Bosch FX
    Vaccine; 2013 Nov; 31 Suppl 8():I58-60. PubMed ID: 24229721
    [No Abstract]   [Full Text] [Related]  

  • 73. Recent increase in incidence of cervical precancerous lesions in Norway: Nationwide study from 1992 to 2016.
    Orumaa M; Leinonen MK; Campbell S; Møller B; Myklebust TÅ; Nygård M
    Int J Cancer; 2019 Nov; 145(10):2629-2638. PubMed ID: 30734284
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of HPV vaccination on HPV infection and cervical related disease burden in real-world settings (HPV-RWS): protocol of a prospective cohort.
    Liu Z; Li P; Zeng X; Yao X; Sun Y; Lin H; Shen P; Sun F; Zhan S
    BMC Public Health; 2022 Nov; 22(1):2117. PubMed ID: 36401179
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study.
    Herweijer E; Feldman AL; Ploner A; Arnheim-Dahlström L; Uhnoo I; Netterlid E; Dillner J; Sparén P; Sundström K
    PLoS One; 2015; 10(7):e0134185. PubMed ID: 26218492
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impact of human papillomavirus vaccination on rates of abnormal cervical cytology and histology in young New Zealand women.
    Innes CR; Williman JA; Simcock BJ; Hider P; Sage M; Dempster-Rivett K; Lawton BA; Sykes PH
    N Z Med J; 2020 Jan; 133(1508):72-84. PubMed ID: 31945044
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cervical Intraepithelial Neoplasia Rates in British Columbia Women: A Population-Level Data Linkage Evaluation of the School-Based HPV Immunization Program.
    Racey CS; Albert A; Donken R; Smith L; Spinelli JJ; Pedersen H; de Bruin P; Masaro C; Mitchell-Foster S; Sadarangani M; Dawar M; Krajden M; Naus M; van Niekerk D; Ogilvie G
    J Infect Dis; 2020 Jan; 221(1):81-90. PubMed ID: 31504649
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Providers' practice, recommendations and beliefs about HPV vaccination and their adherence to guidelines about the use of HPV testing, 2007 to 2010.
    Berkowitz Z; Nair N; Saraiya M
    Prev Med; 2016 Jun; 87():128-131. PubMed ID: 26921654
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cost-effectiveness of HPV vaccination in the prevention of cervical cancer in Malaysia.
    Ezat WP; Aljunid S
    Asian Pac J Cancer Prev; 2010; 11(1):79-90. PubMed ID: 20593935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.